Obstetrical and Gynecological Survey

All-Cause Mortality in Reproductive-Aged Females by State: An Analysis of the Effects of Abortion Legislation.  78:106-108. 2023

Treatment for Mild Chronic Hypertension During Pregnancy.  77:634-636. 2022

Where Are We in Understanding the Natural History of Polycystic Ovary Syndrome? A Systematic Review of Longitudinal Cohort Studies.  77:535-536. 2022

Association of SARS-CoV-2 Infection with Serious Maternal Morbidity and Mortality from Obstetric Complications.  77:457-459. 2022

Changing Patterns in Medication Prescription for Gestational Diabetes during a Time of Guideline Change in the USA: A Cross-Sectional Study.  77:455-457. 2022

Development of a Simplified Patient-Centered Pelvic Floor Surgery Complication Scale.  77:472-473. 2022

Treatment for Mild Chronic Hypertension During Pregnancy.  77:460-462. 2022

A Trial of Hyperimmune Globulin to Prevent Congenital Cytomegalovirus Infection.  77:16-18. 2022

Evaluating Meaningful Levels of Financial Toxicity in Gynecologic Cancers.  76:474-476. 2021

Respiratory Syncytial Virus Vaccination during Pregnancy and Effects in Infants.  76:10-13. 2021

When to operate, hesitate and reintegrate: society of gynecologic oncology surgical considerations during the covid-19 pandemic.  76:88-90. 2021

Low-Dose Aspirin for the Prevention of Preterm Delivery in Nulliparous Women with a Singleton Pregnancy (ASPIRIN): A Randomized, Double-blind, Placebo-Controlled Trial.  75:325-327. 2020

Association of Umbilical Cord Milking vs Delayed Umbilical Cord Clamping with Death or Severe Intraventricular Hemorrhage among Preterm Infants.  75:212-214. 2020

Effect of Behavioral and Pelvic Floor Muscle Therapy Combined With Surgery Versus Surgery Alone on Incontinence Symptoms Among Women With Mixed Urinary Incontinence: The ESTEEM Randomized Clinical Trial.  75:25-27. 2020

Effect of Vaginal Mesh Hysteropexy Versus Vaginal Hysterectomy With Uterosacral Ligament Suspension on Treatment Failure in Women With Uterovaginal Prolapse: A Randomized Clinical Trial.  75:23-25. 2020

Screening for Hepatitis B Virus Infection in Pregnant Women: US Preventive Services Task Force Reaffirmation Recommendation Statement.  74:703-704. 2019

The Efficacy and Safety of Tipapkinogen Sovacivec Therapeutic HPV Vaccine in Cervical Intraepithelial Neoplasia Grades 2 and 3: Randomized Controlled Phase II Trial with 2.5 Years of Follow-up.  74:529-530. 2019

A 12-month clinical durability of effectiveness and safety evaluation of a vaginal bowel control system for the nonsurgical treatment of fecal incontinence.  74:404-405. 2019

Evidence-based review of vaginal native tissue hysteropexy for uterovaginal prolapse.  74:429-435. 2019

Effect of immediate vs delayed pushing on rates of spontaneous vaginal delivery among nulliparous women receiving neuraxial analgesia: A randomized clinical trial.  74:131-133. 2019

Neonatal Outcomes of Elective Early-term Births After Demonstrated Fetal Lung Maturity.  74:66-67. 2019

Screening for Cervical Cancer: US Preventive Services Task Force Recommendation Statement.  73:689-690. 2018

Surgical outcomes after apical repair for vault compared with uterovaginal prolapse.  73:347-348. 2018

Association of Pharmacologic Treatment of Urgency Urinary Incontinence with Sleep Quality and Daytime Sleepiness.  73:273-274. 2018

Effect of Therapeutic Hypothermia Initiated after 6 Hours of Age on Death or Disability among Newborns with Hypoxic-Ischemic Encephalopathy: A Randomized Clinical Trial.  73:141-143. 2018

The FL/AC Ratio for Prediction of Shoulder Dystocia in Women with Gestational Diabetes.  73:129-130. 2018

Lessons Learned from Domestic and International Human Papillomavirus Vaccination Programs: A Review.  73:94-95. 2018

Contraception after Delivery among Publicly Insured Women in Texas: Use Compared with Preference.  73:5-6. 2018

Menopausal Hormone Therapy and Long-Term All-Cause and Cause-Specific Mortality: The Women's Health Initiative Randomized Trials.  73:22-24. 2018

Characteristics Associated with Treatment Response and Satisfaction in Women Undergoing OnabotulinumtoxinA and Sacral Neuromodulation for Refractory Urgency Urinary Incontinence.  72:709-711. 2017

Comparison of Vaginal Hysterectomy Techniques and Interventions for Benign Indications: A Systematic Review.  72:533-534. 2017

Screening for Preeclampsia: US Preventive Services Task Force Recommendation Statement.  72:515-517. 2017

Treatment of subclinical hypothyroidism or hypothyroxinemia in pregnancy.  72:464-465. 2017

Readmission and Prolapse Recurrence after Abdominal and Vaginal Apical Suspensions in Older Women.  72:161-163. 2017

Adjunctive Azithromycin Prophylaxis for Cesarean Delivery.  72:71-73. 2017

Global, regional, and national levels of maternal mortality, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015.  72:11-13. 2017

Antenatal betamethasone for women at risk for late preterm delivery.  71:453-455. 2016

Weekly Versus Every-3-Week Paclitaxel and Carboplatin for Ovarian Cancer.  71:344-345. 2016

Delayed Cord Clamping in Preterm Neonates: A Review of Benefits and Risks.  71:39-42. 2016

Trends in Care Practices, Morbidity, and Mortality of Extremely Preterm Neonates, 1993-2012.  71:7-9. 2016

A Randomized Trial of Intrapartum Fetal ECG ST-Segment Analysis.  70:735-737. 2015

Sexual Health in America: Improving Patient Care and Public Health.  70:752-754. 2015

Between-hospital variation in treatment and outcomes in extremely preterm infants.  70:549-551. 2015

Valganciclovir for Symptomatic Congenital Cytomegalovirus Disease.  70:489-490. 2015

A 9-valent HPV vaccine against infection and intraepithelial Neoplasia in women.  70:446-448. 2015

Tenofovir-based preexposure prophylaxis for HIV infection among African women.  70:444-446. 2015

A population-based, multifaceted strategy to implement antenatal corticosteroid treatment versus standard care for the reduction of neonatal mortality due to preterm birth in low-income and middle-income countries: The ACT cluster randomized trial.  70:379-381. 2015

A vaginal bowel-control system for the treatment of fecal incontinence.  70:387-388. 2015

Effect of depth and duration of cooling on deaths in the NICU among Neonates with hypoxic ischemic encephalopathy: A randomized clinical trial.  70:235-238. 2015

Why do pregnant women die? A review of maternal deaths from 1990 to 2010 at the University of Alabama at Birmingham: Editorial comment.  70:155-157. 2015

Vitamin D deficiency is associated with increased fecal incontinence symptoms.  70:87-88. 2015

American society of clinical oncology position statement on obesity and cancer.  70:28-29. 2015

Bowel preparation before vaginal prolapse surgery: A randomized controlled trial.  69:252-253. 2014

Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the women's health initiative randomized trials.  69:83-85. 2014

Prenatal whole-genome sequencing: Is the quest to know a fetus's future ethical?.  69:197-199. 2014

Urinary bacteria in adult women with urgency urinary incontinence.  69:327-328. 2014

What happens to the posterior compartment and bowel symptoms after sacrocolpopexy?: Evaluation of 5-year outcomes from E-CARE.  69:734-735. 2014

Activity restriction among women with a short cervix.  68:727-728. 2013

Implementing genomic medicine in the clinic: The future is here.  68:621-623. 2013

Urinary incontinence in the 12-month postpartum period.  68:629-630. 2013

Caffeine and urinary incontinence in US women: Editorial comment.  68:432-433. 2013

Incontinence outcomes in women undergoing primary and repeat midurethral sling procedures: Editorial comment.  68:434-435. 2013

Vaginal progesterone, cerclage or cervical pessary for preventing preterm birth in asymptomatic singleton pregnant women with a history of preterm birth and a sonographic short cervix: Editorial comment.  68:425-427. 2013

Measuring outcomes in urogynecological surgery: Perspective is everything.  68:355-357. 2013

Anticholinergic therapy vs. OnabotulinumtoxinA for urgency urinary incontinence.  68:102-104. 2013

Abnormal expression of genes involved in inflammation, lipid metabolism, and Wnt signaling in the adipose tissue of polycystic ovary syndrome.  67:707-709. 2012

A midurethral sling to reduce incontinence after vaginal prolapse repair.  67:629-631. 2012

A randomized trial of urodynamic testing before stress-incontinence surgery.  67:628-629. 2012

Association of antenatal corticosteroids with mortality and neurodevelopmental outcomes among infants born at 22 to 25 weeks' gestation.  67:215-217. 2012

Health outcomes after stopping conjugated equine estrogens among postmenopausal women with prior hysterectomy: A randomized controlled trial.  66:427-429. 2011

Polycystic ovary syndrome and risk for long-term diabetes and dyslipidemia.  66:285-287. 2011

DHEA-S levels and cardiovascular disease mortality in postmenopausal women: Results from the National Institutes of Health-National Heart, Lung, and Blood Institute (NHLBI)-Sponsored Women's Ischemia Syndrome Evaluation (WISE).  66:143-144. 2011

Weight and metabolic outcomes after 2 years on a low-carbohydrate versus low-fat diet.  65:769-770. 2010

17-alpha-hydroxyprogesterone caproate for the prevention of preterm birth in women with prior preterm birth and a short cervical length.  65:477-478. 2010

Dried blood spot real-time polymerase chain reaction assays to screen newborns for congenital cytomegalovirus infection.  65:484-485. 2010

Outcome of term infants using apgar scores at 10 minutes following hypoxic-ischemic encephalopathy.  65:217-218. 2010

A multicenter, randomized trial of treatment for mild gestational diabetes.  65:69-70. 2010

Multicenter randomized trial of cerclage for preterm birth prevention in high-risk women with shortened midtrimester cervical length.  65:73-74. 2010

Effects of periodontal therapy on rate of preterm delivery: A randomized controlled trial.  65:6-7. 2010

Vaccine prevention of maternal cytomegalovirus infection.  64:502-504. 2009

Zoledronic acid and risedronate in the prevention and treatment of glucocorticoid-induced osteoporosis (health outcomes and reduced incidence with zoledronic acid once yearly trial): A multicentre, double-blind, double-dummy, randomized controlled trial.  64:521-523. 2009

Timing of elective repeat cesarean delivery at term and neonatal outcomes.  64:293-295. 2009

Weight loss to treat urinary incontinence in overweight and obese women.  64:317-318. 2009

Levels of sex steroid and cardiovascular disease measures in premenopausal and hormone-treated women at midlife implications for the "timing hypothesis".  64:174-176. 2009

Factors associated with 5-year risk of hip fracture in postmenopausal women.  63:234-235. 2008

Teriparatide or alendronate in glucocorticoid-induced osteoporosis.  63:232-233. 2008

Heritability of dehydroepiandrosterone sulfate in women with polycystic ovary syndrome and their sisters: Commentary.  62:245-247. 2007

Interconceptional antibiotics to prevent spontaneous preterm birth: A randomized clinical trial.  61:496-497. 2006

Low-Fat dietary pattern and risk of invasive breast cancer: The women's health initiative randomized controlled dietary modification trial.  61:454-456. 2006

Low-fat dietary pattern and risk of cardiovascular disease: The women's health initiative randomized controlled dietary modification trial.  61:451-453. 2006

Low-fat dietary pattern and risk of colorectal cancer: The women's health initiative randomized controlled dietary modification trial.  61:456-458. 2006

Calcium plus vitamin D supplementation and the risk of colorectal cancer: Commentary.  61:389-390. 2006

Calcium plus vitamin D supplementation and the risk of fractures: Commentary.  61:386-388. 2006

Subclinical hypothyroidism and pregnancy.  61:415-420. 2006

Effectiveness of treatment strategies of some women with pelvic inflammatory disease.  61:23-25. 2006

A cost-effectiveness analysis of screening strategies for cervical intraepithelial neoplasia.  60:96-97. 2005

Bacterial vaginosis and risk of pelvic inflammatory disease.  60:99-100. 2005

Vulvovaginal symptoms in women with bacterial vaginosis.  60:26-28. 2005

Common complementary and alternative therapies for yeast vaginitis and bacterial vaginosis: A systematic review.  58:351-358. 2003

A guest editorial: Stump the professor.  57:785-787. 2002

Impact of Maternal Group B Streptococcal Screening on Pediatric Management in Full-Term Newborns.  52:168-169.. 1997

Necrotizing fasciitis after cesarean delivery.  89:409-412. 1997

Second-trimester maternal serum ca-125 versus estriol in the multiple-marker screening test for down syndrome.  89:359-363. 1997

Longitudinal changes in adiposity associated with pregnancy: The cardia study.  50:4-6. 1995

Open laparoscopy without special instruments or sutures: Comparison with a closed technique.  49:687-688. 1994

Physicians’ behavior and their interactions with drug companies: A controlled study of physicians who requested additions to a hospital drug formulary.  49:550-553. 1994

Vaginal delivery from the persistent occiput posterior position: Influence on maternal and neonatal morbidity.  49:530-532. 1994

A matched comparison of single and triple incision techniques for the surgical treatment of carcinoma of the vulva.  48:125-126. 1993

Cross-sectional study examining the relationship between fetal urine production and the amniotic fluid index at 38–43 weeks of gestation.  48:728-729. 1993

Hypothalamic-pituitary dysfunction after radiation for brain tumors.  48:428-432. 1993

The outcome of congenital cytomegalovirus infection in relation to maternal antibody status.  47:544-546. 1992

Predictors of morbidity and mortality in neonates with herpes simplex virus infections.  46:451-453. 1991

21-Hydroxylase deficiency in female hyperandrogenism: Screening and Diagnosis.  45:132-133. 1990

Difference between herpes simplex virus type 1 and type 2 neonatal encephalitis in neurological outcome.  43:543-545. 1988

Treatment of condyloma acuminatum with three different interferons administered intralesionallv: a double blind placebo controlled trial.  43:701-702. 1988

Bromocriptine as primary therapy for prolactin-secreting macroadenomas: Results of a prospective multicenter study.  41:48-50. 1986

Early repair of an external sphincter ani muscle and rectal mucosal dehiscence.  41:696-697. 1986

Bromocriptine as primary therapy for prolactin secreting macroadenomas; results of a prospective multicenter study.  40:649-650. 1985

High dose ketoconazole therapy and adrenal and testicular function in humans.  40:374-375. 1985

Cesarean section: Changing incidence and indications.  39:437-438. 1984

Microbiologic study of infertile women at the time of diagnostic laparoscopy: Association of ureaplasrna urealyticurn with a defined subpopulation.  39:110-111. 1984

Retinopathy in toxemia of pregnancy.  36:485-486. 1981

The natural history of herpes simplex virus infection of mother and newborn.  36:359-361. 1981

The effects of exogenous estrogen replacement therapy of the breast: Breast cancer risk and mammographic parenchymal patterns.  35:735-736. 1980

A role of fetal prolactin in lung maturation.  33:516-517. 1978

Evaluation of tetracycline or penicillin and ampicillin for treatment of acute pelvic inflammatory disease.  32:754-756. 1977

The contribution of endocervical smears to cervical cancer detection.  30:768-769. 1975